Amphastar Pharmaceuticals, Inc. (AMPH) is a publicly traded Healthcare sector company. As of May 21, 2026, AMPH trades at $18.07 with a market cap of $758.40M and a P/E ratio of 10.47. AMPH moved +1.35% today. Year to date, AMPH is -32.34%; over the trailing twelve months it is -27.88%. Its 52-week range spans $16.65 to $53.96. Analyst consensus is neutral with an average price target of $22.00. Rallies surfaces AMPH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Amphastar Pharmaceuticals, Inc. (AMPH) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. AMPH moved +1.35% today. Analyst consensus is neutral.
| Metric | Value |
|---|---|
| Price | $18.07 |
| Market Cap | $758.40M |
| P/E Ratio | 10.47 |
| EPS | $1.71 |
| Dividend Yield | 0.00% |
| 52-Week High | $53.96 |
| 52-Week Low | $16.65 |
| Volume | 749.86K |
| Avg Volume | 0 |
| Revenue (TTM) | $720.53M |
| Net Income | $79.23M |
| Gross Margin | 47.34% |
6 analysts cover AMPH: 0 strong buy, 0 buy, 6 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $22.00.